See All Slides - tctmd.com

Slides

Presentation TCT 2013

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Presenter: Masato Nakamura

October 29, 2013

Presentation TCT 2013

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Presenter: Peter Smits

October 29, 2013

Presentation TCT 2013

TCT-51. Prognostic impact of chronic total occlusion in patients with different severity of coronary artery disease - A report from the Swedish Coronary Angiography and...

Presenter: Truls R?munddal

October 29, 2013

Presentation TCT 2013

Non-cellular Therapies in the Clinic: SDF-1 and Other Agents

Presenter: Marc Penn

October 29, 2013

Presentation TCT 2013

Update on ADSCs and MPCs for STEMI

Presenter: Henricus Duckers

October 29, 2013

$Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO$

Presentation TCT 2013

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Presenter: Timothy Henry

October 29, 2013

Presentation

Building A New PCI Pathway

Presenter: Ehtisham Mahmud

October 29, 2013

Presentation TCT 2013

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Presenter: Nils Johnson

October 29, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

Presentation TCT 2013

TCT-111. A Fully-Coupled Fluid Structure Interaction Simulation of Transcatheter Aortic Valve: Implication for Long-Term Valve Durability

Presenter: Ali Azadani

October 29, 2013

Advertisement

Slides

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

TCT-51. Prognostic impact of chronic total occlusion in patients with different severity of coronary artery disease - A report from the Swedish Coronary Angiography and...

Non-cellular Therapies in the Clinic: SDF-1 and Other Agents

Update on ADSCs and MPCs for STEMI

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Building A New PCI Pathway

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

TCT-111. A Fully-Coupled Fluid Structure Interaction Simulation of Transcatheter Aortic Valve: Implication for Long-Term Valve Durability

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content